BETHLEHEM, Pa., Aug. 9, 2011 /PRNewswire/ — In its
efforts to further advance best practices with the continuous
improvement of safety, B. Braun Medical Inc. (B. Braun) announced
today that its OnGuard™ Contained Medication System can help
increase institution and new legislation compliance regarding the
protection of healthcare workers from exposure to hazardous
drugs.
(Logo:
http://photos.prnewswire.com/prnh/20081022/NYW008LOGO)
Senate Bill 5594 has recently directed The Washington State
Department of Labor & Industries to adopt requirements for the
handling of hazardous drugs in protecting healthcare workers from
occupational drug exposure. Rules focused on proper
ventilation, protective equipment, and safe handling
practices have been addressed in detail. Amid many reports
nationally on the adverse health effects of occupational hazardous
drug exposure, Washington is the first state in the nation to
require such protection for its workers.
Studies have shown certain drugs, such as chemotherapy agents,
can be associated with a variety of both short-term and long-term
health effects.(1) OnGuard is a next-generation closed
system drug-transfer device. The innovative drug admixture and
delivery system meets The American Society of Health-System
Pharmacists (ASHP), National Institute for Occupational Safety and
Health (NIOSH) and USP <797> safety guidelines and provides a
new level of hazard protection for pharmacists and nurses on the
frontline of chemotherapy preparation and administration.
“When you’re preparing chemo every day and there is the looming
threat of exposure to hazardous vapors, protecting your personal
safety is of the utmost importance,” said Chris Mangen of the Lucy
Curci Cancer Center in Rancho Mirage, Calif. “The OnGuard system is
easy-to-use and safe, helping eliminate the risks associated with
typical chemo preparation.”
Prior to Bill 5594, ASHP, NI
‘/>”/>
